Surgical management for large vestibular schwannomas: a systematic review, meta-analysis, and consensus statement on behalf of the EANS skull base section.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
11 2020
Historique:
received: 15 06 2020
accepted: 10 07 2020
pubmed: 31 7 2020
medline: 24 4 2021
entrez: 31 7 2020
Statut: ppublish

Résumé

The optimal management of large vestibular schwannomas continues to be debated. We constituted a task force comprising the members of the EANS skull base committee along with international experts to derive recommendations for the management of this problem from a European perspective. A systematic review of MEDLINE database, in compliance with the PRISMA guidelines, was performed. A subgroup analysis screening all surgical series published within the last 20 years (January 2000 to March 2020) was performed. Weighted summary rates for tumor resection, oncological control, and facial nerve preservation were determined using meta-analysis models. This data along with contemporary practice patterns were discussed within the task force to generate consensual recommendations regarding preoperative evaluations, optimal surgical strategy, and follow-up management. Tumor classification grades should be systematically used in the perioperative management of patients, with large vestibular schwannomas (VS) defined as > 30 mm in the largest extrameatal diameter. Grading scales for pre- and postoperative hearing (AAO-HNS or GR) and facial nerve function (HB) are to be used for reporting functional outcome. There is a lack of consensus to support the superiority of any surgical strategy with respect to extent of resection and use of adjuvant radiosurgery. Intraoperative neuromonitoring needs to be routinely used to preserve neural function. Recommendations for postoperative clinico-radiological evaluations have been elucidated based on the surgical strategy employed. The main goal of management of large vestibular schwannomas should focus on maintaining/improving quality of life (QoL), making every attempt at facial/cochlear nerve functional preservation while ensuring optimal oncological control, thereby allowing to meet patient expectations. Despite the fact that this analysis yielded only a few Class B evidences and mostly expert opinions, it will guide practitioners to manage these patients and form the basis for future clinical trials.

Sections du résumé

BACKGROUND AND OBJECTIVE
The optimal management of large vestibular schwannomas continues to be debated. We constituted a task force comprising the members of the EANS skull base committee along with international experts to derive recommendations for the management of this problem from a European perspective.
MATERIAL AND METHODS
A systematic review of MEDLINE database, in compliance with the PRISMA guidelines, was performed. A subgroup analysis screening all surgical series published within the last 20 years (January 2000 to March 2020) was performed. Weighted summary rates for tumor resection, oncological control, and facial nerve preservation were determined using meta-analysis models. This data along with contemporary practice patterns were discussed within the task force to generate consensual recommendations regarding preoperative evaluations, optimal surgical strategy, and follow-up management.
RESULTS
Tumor classification grades should be systematically used in the perioperative management of patients, with large vestibular schwannomas (VS) defined as > 30 mm in the largest extrameatal diameter. Grading scales for pre- and postoperative hearing (AAO-HNS or GR) and facial nerve function (HB) are to be used for reporting functional outcome. There is a lack of consensus to support the superiority of any surgical strategy with respect to extent of resection and use of adjuvant radiosurgery. Intraoperative neuromonitoring needs to be routinely used to preserve neural function. Recommendations for postoperative clinico-radiological evaluations have been elucidated based on the surgical strategy employed.
CONCLUSION
The main goal of management of large vestibular schwannomas should focus on maintaining/improving quality of life (QoL), making every attempt at facial/cochlear nerve functional preservation while ensuring optimal oncological control, thereby allowing to meet patient expectations. Despite the fact that this analysis yielded only a few Class B evidences and mostly expert opinions, it will guide practitioners to manage these patients and form the basis for future clinical trials.

Identifiants

pubmed: 32728903
doi: 10.1007/s00701-020-04491-7
pii: 10.1007/s00701-020-04491-7
pmc: PMC7550309
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2595-2617

Références

Otol Neurotol. 2017 Apr;38(4):473-483
pubmed: 28196001
Arch Otolaryngol Head Neck Surg. 2007 Jan;133(1):56-60
pubmed: 17224525
Otolaryngol Head Neck Surg. 2016 Aug;155(2):317-23
pubmed: 27095048
J Neurooncol. 2014 Jan;116(1):187-93
pubmed: 24142200
Otol Neurotol. 2003 Jul;24(4):642-8; discussion 648-9
pubmed: 12851559
J Craniofac Surg. 2014 Mar;25(2):463-8
pubmed: 24514888
Stereotact Funct Neurosurg. 2016;94(4):216-224
pubmed: 27513938
J Neurooncol. 2006 Apr;77(2):167-71
pubmed: 16397752
Otol Neurotol. 2018 Jun;39(5):e381-e386
pubmed: 29738391
Otol Neurotol. 2015 Jul;36(6):965-71
pubmed: 25931165
Acta Otolaryngol. 2008 Aug;128(8):881-6
pubmed: 18607969
J Neurosurg. 2014 May;120(5):1095-104
pubmed: 24527822
J Laryngol Otol. 2014 May;128(5):406-15
pubmed: 24685071
Acta Neurochir (Wien). 2005 Jul;147(7):697-706; discussion 706
pubmed: 15900399
Laryngoscope. 2003 Aug;113(8):1332-43
pubmed: 12897555
J Neurosurg. 1949 Sep;6(5):396-407
pubmed: 18141045
J Neurosurg. 2011 Nov;115(5):885-93
pubmed: 21838503
Otolaryngol Head Neck Surg. 2008 May;138(5):667-71
pubmed: 18439476
Neurol Med Chir (Tokyo). 1999 Feb;39(2):141-7; discussion 147-9
pubmed: 10193147
J Neurosurg. 2018 Jul;129(1):137-145
pubmed: 28984523
J Neurosurg. 2009 Oct;111(4):845-54
pubmed: 19344218
Otol Neurotol. 2002 May;23(3):388-92
pubmed: 11981400
Otolaryngol Head Neck Surg. 2018 Sep;159(3):535-542
pubmed: 29685084
Eye (Lond). 2011 Oct;25(10):1322-6
pubmed: 21720412
World Neurosurg. 2017 Jul;103:231-240
pubmed: 28223251
Otol Neurotol. 2011 Jan;32(1):125-31
pubmed: 21131891
Skull Base. 2002 Nov;12(4):189-95
pubmed: 17167678
Neurosurg Rev. 2016 Apr;39(2):303-12; discussion 312
pubmed: 26782633
Audiol Neurootol. 2008;13(1):58-64
pubmed: 17890858
Otol Neurotol. 2013 Feb;34(2):304-10
pubmed: 23444478
Laryngoscope. 2001 Mar;111(3):387-98
pubmed: 11224766
J Neurosurg. 2012 Dec;117 Suppl:69-77
pubmed: 23205792
J Neurosurg. 2014 Dec;121 Suppl:150-9
pubmed: 25434948
Neurosurgery. 2005 May;56(5):927-35; discussion 927-35
pubmed: 15854240
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Neurosurgery. 2019 Jul 1;85(1):E125-E136
pubmed: 30476219
Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2373-83
pubmed: 26498948
Neurotherapeutics. 2019 Jan;16(1):36-51
pubmed: 30542904
Otolaryngol Head Neck Surg. 1985 Apr;93(2):146-7
pubmed: 3921901
Neurosurgery. 1997 Jan;40(1):11-21; discussion 21-3
pubmed: 8971819
Neurosurg Focus. 2005 Apr 15;18(4):e9
pubmed: 15844872
Neurosurgery. 2013 Jun;72(2 Suppl Operative):ons103-15; discussion ons115
pubmed: 23037828
World Neurosurg. 2018 Jun;114:e1192-e1198
pubmed: 29614352
Am J Otolaryngol. 2013 Mar-Apr;34(2):107-14
pubmed: 23177377
J Neurosurg. 2010 Dec;113 Suppl:122-27
pubmed: 21222292
Skull Base. 2004 May;14(2):85-90; discussion 90-1
pubmed: 16145589
Neurol India. 2005 Mar;53(1):41-5; discussion 45
pubmed: 15805654
Bangladesh Med Res Counc Bull. 2011 Dec;37(3):92-6
pubmed: 22352228
J Clin Neurosci. 2015 Feb;22(2):320-5
pubmed: 25443082
Laryngoscope. 2007 Dec;117(12):2087-92
pubmed: 17921903
World Neurosurg. 2018 Oct;118:e895-e905
pubmed: 30031182
Eur Ann Otorhinolaryngol Head Neck Dis. 2010 May;127(2):63-9
pubmed: 20822759
Laryngoscope. 2012 Feb;122(2):378-88
pubmed: 22252688
Neurosurgery. 2009 Apr;64(4):654-61; discussion 661-3
pubmed: 19197222
Laryngoscope. 2004 Apr;114(4):681-8
pubmed: 15064624
Laryngoscope. 2000 Sep;110(9):1539-42
pubmed: 10983957
Arch Otolaryngol. 1966 Sep;84(3):245-6
pubmed: 5946806
AJNR Am J Neuroradiol. 2000 May;21(5):810-6
pubmed: 10815653
Eur Arch Otorhinolaryngol. 2017 Jun;274(6):2437-2442
pubmed: 28391530
Neurosurgery. 2018 Feb 1;82(2):E44-E46
pubmed: 29309641
Neurosurgery. 2006 Jul;59(1):77-85; discussion 77-85
pubmed: 16823303
J Clin Neurophysiol. 2011 Dec;28(6):566-81
pubmed: 22146352
Ann Otol Rhinol Laryngol. 2006 Sep;115(9):694-8
pubmed: 17044542
J Neurosurg. 2011 Nov;115(5):917-23
pubmed: 21854113
Otol Neurotol. 2002 Mar;23(2):224-7
pubmed: 11875354
Laryngoscope. 2010 Aug;120(8):1646-54
pubmed: 20641085
World Neurosurg. 2016 Jun;90:385-390
pubmed: 26987634
Surg Neurol. 2000 Apr;53(4):370-7; discussion 377-8
pubmed: 10825523
Neurol India. 2009 May-Jun;57(3):257-63
pubmed: 19587464
J Neurosurg. 1998 Dec;89(6):949-55
pubmed: 9833821
Otol Neurotol. 2018 Oct;39(9):e860-e871
pubmed: 30106846
J Neurosurg. 2006 Aug;105(2):205-12
pubmed: 17219824
Otolaryngol Head Neck Surg. 2005 Jan;132(1):11-9
pubmed: 15632903
Mol Cancer Ther. 2017 Nov;16(11):2387-2398
pubmed: 28775147
Neurosurgery. 2020 Mar 1;86(3):410-416
pubmed: 31232426
ANZ J Surg. 2005 Oct;75(10):893-6
pubmed: 16176235
J Neurosurg. 2008 Nov;109(5):811-6
pubmed: 18976069
Otol Neurotol. 2018 Jan;39(1):e12-e19
pubmed: 29210952
Otol Neurotol. 2017 Oct;38(9):1339-1344
pubmed: 28796091
J Neurosurg. 2019 Apr 19;:1-11
pubmed: 31003214
J Neurosurg. 2008 Jul;109(1):70-6
pubmed: 18590434
HNO. 2020 Jan;68(Suppl 1):1-10
pubmed: 31478063
J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):453-8
pubmed: 14966164
J Neurol Surg B Skull Base. 2012 Apr;73(2):117-20
pubmed: 23542125
Chin Med J (Engl). 2007 Feb 20;120(4):323-5
pubmed: 17374285
Surg Neurol. 2003 Apr;59(4):283-9; discussion 289-91
pubmed: 12748011
Stereotact Funct Neurosurg. 2007;85(4):184-91
pubmed: 17389818
World Neurosurg. 2013 Dec;80(6):e271-300
pubmed: 22120256
Neuro Oncol. 2020 Jan 11;22(1):31-45
pubmed: 31504802
Neurosurgery. 2011 Mar;68(3):632-40; discussion 640
pubmed: 21164374
Audiol Neurootol. 2012;17(2):71-81
pubmed: 21829012
Curr Opin Otolaryngol Head Neck Surg. 2012 Oct;20(5):380-4
pubmed: 22954813
World Neurosurg. 2016 Oct;94:137-144
pubmed: 27392890
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e503-9
pubmed: 21665381
J Neurosurg. 2006 Oct;105(4):527-35
pubmed: 17044553
Clin Neurol Neurosurg. 2015 Jun;133:83-9
pubmed: 25867236
J Neurosurg. 2005 Apr;102(4):643-9
pubmed: 15871506
Ann Otol Rhinol Laryngol. 2004 Apr;113(4):319-28
pubmed: 15112977
Otol Neurotol. 2003 May;24(3):460-4
pubmed: 12806299
Neurology. 1992 Aug;42(8):1551-3
pubmed: 1641152
Otolaryngol Head Neck Surg. 1995 Sep;113(3):179-80
pubmed: 7675475
World Neurosurg. 2015 Aug;84(2):292-300
pubmed: 25790872
Neurosurg Focus. 2018 Mar;44(3):E4
pubmed: 29490553
Neurosurg Focus. 2018 Mar;44(3):E5
pubmed: 29490547
Laryngoscope. 2016 Nov;126(11):2580-2586
pubmed: 27107262
Clin Epidemiol. 2019 Nov 08;11:981-986
pubmed: 31807080
Radiother Oncol. 2015 Mar;114(3):378-83
pubmed: 25702864
J Neurosurg. 2010 Apr;112(4):860-7
pubmed: 19663543
Acta Otolaryngol. 2010 Nov;130(11):1249-55
pubmed: 20443757
Neurosurg Focus. 2018 Mar;44(3):E2
pubmed: 29490546
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):431-6
pubmed: 17673492
Laryngoscope. 2003 Mar;113(3):420-6
pubmed: 12616190
J Neurosurg. 2012 Apr;116(4):713-20
pubmed: 22264180
AJNR Am J Neuroradiol. 2009 May;30(5):985-91
pubmed: 19193761
J Neurosurg. 2002 Nov;97(5):1091-100
pubmed: 12450031
Neurol Med Chir (Tokyo). 2013;53(7):482-9
pubmed: 23883559
Neurol India. 2016 May-Jun;64(3):478-84
pubmed: 27147157
Prog Neurol Surg. 2008;21:152-157
pubmed: 18810213
J Neurosurg. 2011 May;114(5):1224-31
pubmed: 21214329
Int J Audiol. 2019 Nov;58(11):696-703
pubmed: 31195860
Neuroradiology. 2013 May;55(5):615-20
pubmed: 23411717
J Neurosurg. 2019 Aug 2;:1-7
pubmed: 31374553
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1265-78
pubmed: 11483338
Otolaryngol Clin North Am. 2012 Apr;45(2):257-68, vii
pubmed: 22483814
Acta Neurochir (Wien). 2017 Jul;159(7):1197-1211
pubmed: 28516364
ORL J Otorhinolaryngol Relat Spec. 2012;74(5):271-7
pubmed: 23147594
Eur Arch Otorhinolaryngol. 2011 Feb;268(2):207-12
pubmed: 20835831
J Neurosurg. 2018 May;128(5):1380-1387
pubmed: 28707997
Clin Neurol Neurosurg. 2009 Jan;111(1):47-53
pubmed: 18952367
J Neurosurg. 2005 Jul;103(1):59-63
pubmed: 16121974
Ann Otol Rhinol Laryngol. 1988 Jan-Feb;97(1):55-66
pubmed: 3277525
Auris Nasus Larynx. 2000 Jul;27(3):201-5
pubmed: 10808105
Eur Arch Otorhinolaryngol. 2019 Sep;276(9):2441-2447
pubmed: 31177326
Laryngoscope. 2014 Oct;124(10):2247-51
pubmed: 24496778
Acta Neurochir (Wien). 2013 Jan;155(1):71-4; discussion 74
pubmed: 23160632
Laryngoscope. 2019 Jan;129(1):100-104
pubmed: 30208215
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
Am J Otolaryngol. 2013 May-Jun;34(3):195-204
pubmed: 23332407
Am J Otol. 1993 Nov;14(6):524-32
pubmed: 8296853
World Neurosurg. 2014 Feb;81(2):357-67
pubmed: 23022637
J Laryngol Otol. 2010 Mar;124(3):258-64
pubmed: 19922702
Otolaryngol Head Neck Surg. 2001 Jun;124(6):645-51
pubmed: 11391255
World Neurosurg. 2019 Sep;129:e114-e127
pubmed: 31100515
Otolaryngol Head Neck Surg. 2004 Jan;130(1):104-12
pubmed: 14726918
J Clin Neurosci. 2005 May;12(4):405-8
pubmed: 15925770
Arq Neuropsiquiatr. 2007 Sep;65(3A):605-9
pubmed: 17876399
Otolaryngol Head Neck Surg. 1994 Feb;110(2):146-55
pubmed: 8108149
World Neurosurg. 2012 May-Jun;77(5-6):731-5
pubmed: 22120302
Neurosurgery. 2016 Apr;78(4):521-30
pubmed: 26606668
Neurosurgery. 2015 Aug;77(2):218-27; discussion 227
pubmed: 25850598
Neurosurgery. 2019 Sep 1;85(3):409-414
pubmed: 30169695
Acta Chir Scand. 1951 Dec 13;102(4):316-9
pubmed: 14914373
Otolaryngol Head Neck Surg. 2010 Jan;142(1):115-9
pubmed: 20096234
Minim Invasive Neurosurg. 2005 Feb;48(1):39-43
pubmed: 15747215
Acta Otorhinolaryngol Ital. 2016 Oct;36(5):408-414
pubmed: 27600105
Am J Otol. 1998 Mar;19(2):212-8
pubmed: 9520059
J Neurosurg. 1998 Mar;88(3):506-12
pubmed: 9488305
Neurosurg Rev. 2014 Jan;37(1):15-21
pubmed: 23771647
J Neurosurg. 1967 Jan;26(1):6-13
pubmed: 6018783
Laryngoscope. 2005 Oct;115(10):1827-32
pubmed: 16222204
Otolaryngol Head Neck Surg. 1994 Dec;111(6):703-9
pubmed: 7991247
Otolaryngol Head Neck Surg. 1991 Jun;104(6):814-7
pubmed: 1908973
Otol Neurotol. 2011 Feb;32(2):338-44
pubmed: 21150682
Neurosurgery. 2012 Dec;71(6):1125-30; discussion 1130
pubmed: 22986594
Acta Neurochir (Wien). 2010 Oct;152(10):1647-52
pubmed: 20544362
ORL J Otorhinolaryngol Relat Spec. 1994;56(1):31-5
pubmed: 8121681
BMC Neurol. 2017 Jan 31;17(1):18
pubmed: 28137246
J Neurooncol. 2010 Jun;98(2):203-12
pubmed: 20405307
J Neurooncol. 2011 Apr;102(2):281-6
pubmed: 20694574
Neurosurgery. 2019 Mar 1;84(3):726-732
pubmed: 29889284
World Neurosurg. 2019 Jul;127:e599-e608
pubmed: 30930324
Indian J Otolaryngol Head Neck Surg. 2015 Mar;67(1):21-7
pubmed: 25621227
Front Neurol. 2018 Mar 12;9:136
pubmed: 29593635
Neurosurgery. 2016 Aug;79(2):194-203
pubmed: 26645964
Clin Otolaryngol. 2017 Aug;42(4):815-823
pubmed: 27905190
Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1485-91
pubmed: 20708852
J Neurosurg. 2017 May 19;:1-7
pubmed: 28524795
Otol Neurotol. 2004 Sep;25(5):826-32
pubmed: 15354018
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1390-6
pubmed: 12873685
Eur J Radiol. 1999 Jun;30(3):237-44
pubmed: 10452724
J Neurosurg. 2012 May;116(5):1126-33
pubmed: 22360572
J Neurosurg. 2015 Feb;122(2):303-11
pubmed: 25479119
Oper Neurosurg (Hagerstown). 2017 Aug 1;13(4):441-447
pubmed: 28838116
J Radiosurg SBRT. 2017;5(1):5-24
pubmed: 29296459
J Neurosurg. 2011 Nov;115(5):875-84
pubmed: 21838510
Med J Malaysia. 2013 Jun;68(3):253-8
pubmed: 23749017
Neurosurgery. 2018 Apr 1;82(4):541-547
pubmed: 29554375
Prog Neurol Surg. 2008;21:79-82
pubmed: 18810202
J Neurol Surg B Skull Base. 2019 Dec;80(6):632-639
pubmed: 31750050
J Neurosurg. 2001 Jan;94(1):61-6
pubmed: 11147899

Auteurs

Daniele Starnoni (D)

Department of Neurosurgery Service and Gamma Knife Center, University hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.

Lorenzo Giammattei (L)

Neurosurgical Department, Lariboisière Hospital, Paris, France.

Giulia Cossu (G)

Department of Neurosurgery Service and Gamma Knife Center, University hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.

Michael J Link (MJ)

Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA.

Pierre-Hugues Roche (PH)

Department of Neurosurgery, CHU North Hospital, Aix-Marseille University, Marseille, France.

Ari G Chacko (AG)

Department of Neurological Sciences, Christian Medical College, Vellore, Tamil Nadu, India.

Kenji Ohata (K)

Department of Neurosurgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Majid Samii (M)

Neurosurgery, International Neuroscience Institute, Hannover, Germany.

Ashish Suri (A)

Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.

Michael Bruneau (M)

Department of Neurosurgery, Erasme Hospital, Brussels, Belgium.

Jan F Cornelius (JF)

Department of Neurosurgery, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Luigi Cavallo (L)

Department of Neurosurgery, University Hospital of Naples Federico II, Naples, NA, Italy.

Torstein R Meling (TR)

Department of Neurosurgery, University Hospital of Geneva, Geneva, Switzerland.

Sebastien Froelich (S)

Neurosurgical Department, Lariboisière Hospital, Paris, France.

Marcos Tatagiba (M)

Department of Neurosurgery, Eberhard Karls University of Tübingen, Tübingen, Germany.

Albert Sufianov (A)

Federal Centre of Neurosurgery, Tyumen, Russian Federation; Department of Neurosurgery, The State Education Institution of Higher Professional Training, The First Sechenov Moscow State Medical University under Ministry of Health, Tyumen, Russian Federation.

Dimitrios Paraskevopoulos (D)

Department of Neurosurgery, Barts Health NHS Trust, St. Bartholomew's and The Royal London Hospital, London, UK.

Idoya Zazpe (I)

Servicio de Neurocirugía, Complejo Hospitalario de Navarra, Pamplona, Spain.
Servicio de Cirugía Torácica, Complejo Hospitalario de Navarra, Pamplona, Spain.

Moncef Berhouma (M)

Department of Neurosurgery, Hopital Neurologique Pierre Wertheimer, Lyon, France.

Emmanuel Jouanneau (E)

Department of Neurosurgery, Hopital Neurologique Pierre Wertheimer, Lyon, France.

Jeroen B Verheul (JB)

Department of Neurosurgery and Gamma knife Centre, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands.

Constantin Tuleasca (C)

Department of Neurosurgery Service and Gamma Knife Center, University hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Signal Processing Laboratory (LTS 5) Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne, Lausanne, Switzerland.

Mercy George (M)

ENT Service, Centre Hospitalier Universitaire Vaudois (CHUV); Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Marc Levivier (M)

Department of Neurosurgery Service and Gamma Knife Center, University hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.

Mahmoud Messerer (M)

Department of Neurosurgery Service and Gamma Knife Center, University hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.

Roy Thomas Daniel (RT)

Department of Neurosurgery Service and Gamma Knife Center, University hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland. roy.daniel@chuv.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH